Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Be Well: Why Major Retailers Are Shuttering Doors
Be Well: Why Major Retailers Are Shuttering Doors
Stock Market Today: Wall Street Slips After Tepid Economic Report
U.S. stocks are drifting Monday to begin what could be a quiet stretch following weeks of gains that rallied Wall Street to the edge of what's called a “bull market."
Saudi Arabia Will Slash Oil Production to Boost Prices
It took a unilateral step Sunday to support the sagging cost of crude after two earlier cuts by other OPEC+ countries failed to push prices higher.
How SPAN Looks to Electrify Millions of American Homes
How SPAN Looks to Electrify Millions of American Homes
Tom Brady Talks Broadcasting Career at Fox Sports and Growing Popularity Online Betting
Tom Brady Talks Broadcasting Career at Fox Spots and Growing Popularity Online Betting
The Week Ahead: Apple World Wide Developer Conference & NIO Earnings
The Week Ahead: Apple World Wide Developer Conference & NIO Earnings
Amazon Could Offer Mobile Service With Prime Subscription
Amazon Could Offer Mobile Service With Prime Subscription
Report: Money Stored in Payment Apps May Be Vulnerable
Report: Money Stored in Payment Apps May Be Vulnerable
Airbnb Sues New York City Over Restrictions
Airbnb Sues New York City Over Restrictions
